Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Troponin I at admission in the intensive care unit predicts the need of dialysis in septic patients

Authors: Daniel de Almeida Thiengo, Jorge P. Strogoff-de-Matos, Jocemir Ronaldo Lugon, Miguel Luis Graciano

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

In a previous study we showed that troponin I (TnI) > 0.42 ng/mL predicted the need of dialysis in a group of 29 septic patients admitted to the intensive care unit (ICU). We aimed to confirm such finding in a larger independent sample.

Methods

All septic patients admitted to an ICU from March 2016 to February 2017 were included if age between 18 and 90 years, onset of sepsis < 24 h, normal left ventricular ejection fraction, and no previous coronary or kidney diseases. TnI was measured on day 1. Patients were followed by 30 days or until death.

Results

A total of 120 patients were included (51% male, 74 ± 13 years old). At ICU admission, 70 patients had TnI > 0.42 ng/mL. These patients had serum creatinine slightly higher (1.66 ± 0.34 vs. 1.32 ± 0.39 mg/dL; P <  0.0001) than those with lower TnI and similar urine output (1490 ± 682 vs. 1406 ± 631 mL; P = 0.44). At the end of the follow-up period, 70.0% of the patients with lower TnI were alive in comparison with 38.6% of those with higher TnI (p = 0.0014). After 30 days, 69.3 and 2.9% of the patients with lower and higher TnI levels remained free of dialysis, respectively (p <  0.0001). In a Cox regression model, after adjustment for gender, age, Charlson comorbidity index, serum creatinine, potassium, pH, brain natriuretic peptide and urine output, TnI > 0.42 ng/mL persisted as a strong predictor of dialysis need (hazard ratio 3.48 [95%CI 1.69–7.18]).

Conclusions

TnI levels at ICU admission are a strong independent predictor of dialysis need in sepsis.
Literature
1.
go back to reference Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Cri Care Med. 2001;29(7):1303–10.CrossRef Angus DC, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Cri Care Med. 2001;29(7):1303–10.CrossRef
2.
go back to reference Hoste EA, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1008–10.CrossRef Hoste EA, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1008–10.CrossRef
3.
go back to reference Dellinger RP, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Cri Care Med. 2013;41(5):580–637.CrossRef Dellinger RP, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Cri Care Med. 2013;41(5):580–637.CrossRef
4.
go back to reference Reinhart K, et al. Markers of endothelial damage in organ dysfuncion and sepsis. Cri Care Med. 2002;30(5):302–12.CrossRef Reinhart K, et al. Markers of endothelial damage in organ dysfuncion and sepsis. Cri Care Med. 2002;30(5):302–12.CrossRef
5.
go back to reference Gopaluni S, Lines S, Lewington AJP. Acute kidney injury in critically ill patient. Curr Anaesth Crit Care. 2010;21(5):60–4.CrossRef Gopaluni S, Lines S, Lewington AJP. Acute kidney injury in critically ill patient. Curr Anaesth Crit Care. 2010;21(5):60–4.CrossRef
6.
go back to reference Cruz DN, et al. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. Contrib Nephrol. 2013;182(8):45–64.CrossRef Cruz DN, et al. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. Contrib Nephrol. 2013;182(8):45–64.CrossRef
7.
go back to reference Thiengo DA, Lugon JR, Graciano ML. Troponin I serum levels predict the need of dialysis in incident sepsis patients with acute kidney injury in the intensive care unit. J Bras Nefrol. 2015;37(4):38–43.CrossRef Thiengo DA, Lugon JR, Graciano ML. Troponin I serum levels predict the need of dialysis in incident sepsis patients with acute kidney injury in the intensive care unit. J Bras Nefrol. 2015;37(4):38–43.CrossRef
8.
go back to reference Singer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.CrossRef Singer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.CrossRef
9.
go back to reference Seymour CW, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–74.CrossRef Seymour CW, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–74.CrossRef
10.
go back to reference Belcher JM, et al. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis. 2011;57(6):930–40.CrossRef Belcher JM, et al. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis. 2011;57(6):930–40.CrossRef
11.
go back to reference McCullough PA, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;12(4):182–5. McCullough PA, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;12(4):182–5.
12.
go back to reference Bonventre JV, et al. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 2008;241(9):78–83.CrossRef Bonventre JV, et al. Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scand J Clin Lab Invest Suppl. 2008;241(9):78–83.CrossRef
13.
go back to reference Devarajan P. Review - neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology. 2010;15(2):419–28.CrossRef Devarajan P. Review - neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology. 2010;15(2):419–28.CrossRef
14.
go back to reference Soto K, et al. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting. CJASN. 2013;8(5):2053–63.CrossRef Soto K, et al. Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting. CJASN. 2013;8(5):2053–63.CrossRef
15.
go back to reference Schrier RW, et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;14(7):114–5. Schrier RW, et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;14(7):114–5.
16.
go back to reference Coca SG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;52(6):961–73.CrossRef Coca SG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;52(6):961–73.CrossRef
17.
go back to reference Ammann P, Fehr T, Minder E. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965–9.CrossRef Ammann P, Fehr T, Minder E. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965–9.CrossRef
18.
go back to reference Favory R, Neviere R. Bench-to-bedside review: significance and interpretation of elevated troponin in septic patients. Crit Care. 2006;10(4):224–7.CrossRef Favory R, Neviere R. Bench-to-bedside review: significance and interpretation of elevated troponin in septic patients. Crit Care. 2006;10(4):224–7.CrossRef
19.
go back to reference Hussain N. Elevated cardiac troponins in setting of systemic inflammatory response syndrome, Sepsis, and septic shock. ISRN Cardiol. 2013;37(3):77–85. Hussain N. Elevated cardiac troponins in setting of systemic inflammatory response syndrome, Sepsis, and septic shock. ISRN Cardiol. 2013;37(3):77–85.
20.
go back to reference Altmann DR, Korte W, Maeder MT. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One. 2010;5(2):216–20.CrossRef Altmann DR, Korte W, Maeder MT. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One. 2010;5(2):216–20.CrossRef
21.
go back to reference Yao X, Carlson D, Sun Y. Mitochondrial ROS induces cardiac inflammation via a pathway through mtDNA damage in a pneumonia-related Sepsis model. PLoS One. 2015;19(8):1527–39. Yao X, Carlson D, Sun Y. Mitochondrial ROS induces cardiac inflammation via a pathway through mtDNA damage in a pneumonia-related Sepsis model. PLoS One. 2015;19(8):1527–39.
22.
go back to reference Miller-Hodges E, Anand A, Shah ASV. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137(6):425–35.CrossRef Miller-Hodges E, Anand A, Shah ASV. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137(6):425–35.CrossRef
23.
go back to reference Abbas NA, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51(2):2059–66.CrossRef Abbas NA, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51(2):2059–66.CrossRef
24.
go back to reference Levin A, Kellum JA, Mehta RL. Acute kidney injury: toward an integrated understanding through development of a research agenda. Acute kidney injury network (AKIN). Clin J Soc Nephrol. 2008;3(7):862–3.CrossRef Levin A, Kellum JA, Mehta RL. Acute kidney injury: toward an integrated understanding through development of a research agenda. Acute kidney injury network (AKIN). Clin J Soc Nephrol. 2008;3(7):862–3.CrossRef
25.
go back to reference Hall IE, et al. Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis. Clin J Soc Nephrol. 2011;6(3):2740–9.CrossRef Hall IE, et al. Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis. Clin J Soc Nephrol. 2011;6(3):2740–9.CrossRef
26.
go back to reference Siew ED, et al. Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function. Kidney Int. 2013;84(4):786–94.CrossRef Siew ED, et al. Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function. Kidney Int. 2013;84(4):786–94.CrossRef
27.
go back to reference Doi K, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Cri Care Med. 2010;38(10):2037–42.CrossRef Doi K, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Cri Care Med. 2010;38(10):2037–42.CrossRef
Metadata
Title
Troponin I at admission in the intensive care unit predicts the need of dialysis in septic patients
Authors
Daniel de Almeida Thiengo
Jorge P. Strogoff-de-Matos
Jocemir Ronaldo Lugon
Miguel Luis Graciano
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1129-5

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue